These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18218241)

  • 1. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study of multivariable model in predicting response to immunosuppressive therapy in patients with aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF; Yu Z; Chang YL; Zhou YW
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):583-6. PubMed ID: 18246811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
    Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
    Huang YL; Huang SL; Huang K; Bao R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.
    Hara T; Ando K; Tsurumi H; Moriwaki H
    Eur J Haematol; 2004 Jul; 73(1):10-6. PubMed ID: 15182332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
    Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study on predictors for selection of immunosuppressive therapy or androgens in treating aplastic anemia patients].
    Tang XD; Zhang SS; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):106-10. PubMed ID: 19382467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of immunosuppressive therapy for childhood aplastic anemia and its predictive factors].
    Zhao FY; Xu XJ; Song H; Yang SL; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):567-70. PubMed ID: 22898273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia.
    Xing L; Liu C; Fu R; Wang H; Wang J; Liu X; Feng L; Li L; Liu H; Wang H; Zhang T; Shao Z
    Mol Med Rep; 2014 Sep; 10(3):1252-8. PubMed ID: 24969051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
    Nakao S; Takami A; Sugimori N; Ueda M; Shiobara S; Matsuda T; Mizoguchi H
    Br J Haematol; 1996 Jan; 92(1):155-8. PubMed ID: 8562389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*15 and pediatric aplastic anemia.
    Oguz FS; Yalman N; Diler AS; Oguz R; Anak S; Dorak MT
    Haematologica; 2002 Jul; 87(7):772-4. PubMed ID: 12091130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanism of aplastic anemia.
    Nakao S
    Int J Hematol; 1997 Aug; 66(2):127-34. PubMed ID: 9277043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ancestry of the HLA-DRB1*15 allele predisposes the Mexican mestizo to the development of aplastic anemia.
    Fernández-Torres J; Flores-Jiménez D; Arroyo-Pérez A; Granados J; López-Reyes A
    Hum Immunol; 2012 Aug; 73(8):840-3. PubMed ID: 22580214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
    Sun YX; Zhu MQ; He GS; Wang XL; Fang BZ; Lu C; Liu ZZ; Wu Q; Yang Y; Wu DP; Sun AN
    Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):585-9. PubMed ID: 24267002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
    Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
    Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
    Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.